首页 | 本学科首页   官方微博 | 高级检索  
检索        

磷酸化血小板衍生生长因子受体-α在非小细胞肺癌中的表达及其临床意义
引用本文:邹斌,杨宇,罗荧荃.磷酸化血小板衍生生长因子受体-α在非小细胞肺癌中的表达及其临床意义[J].疑难病杂志,2008,7(5):272-276.
作者姓名:邹斌  杨宇  罗荧荃
作者单位:中南人学湘雅第二医院老年科,长沙,410011
摘    要:目的探讨磷酸化血小板衍生生长因子受体-α(P-PDGFR-α)在非小细胞肺癌(NSCLC)中的表达及与其发展、转移的关系。方法共525例NSCLC患者纳入研究。运用Envision免疫组织化学法检测各患者组织标本中P-PDGFR-α的表达情况。结果525例患者中,42例P-PDGFR-α呈阳性(阳性率8.0%)。男女患者间及各年龄组患者差异无统计学意义(P>0.05),292例鳞癌患者中21例呈阳性(阳性率7.2%),222例腺癌标本中21例呈阳性(阳性率9.5%),11例腺鳞癌组织中均无阳性表达,三者之间差异均无统计学意义(P>0.05);P-PDGFR-α在低分化NSCLC患者中的表达显著高于高分化及中分化NSCLC的表达(P<0.05);266例手术大标本中,有淋巴结转移的145例患者中26例呈阳性(阳性率18.0%),而无淋巴结转移的121例患者中8例呈阳性(阳性率6.7%),两者比较差异有统计学意义(P<0.05)。结论(1)P-PDGFR-α可能与NSCLC的发展和转移有关;(2)P-PDGFR-α在NSCLC中的表达与年龄、性别、NSCLC病理学类型无关。

关 键 词:非小细胞肺癌  磷酸化血小板衍生生长因子受体-α  靶向治疗
文章编号:1671-6450(2008)05-0272-04
修稿时间:2007年12月21

The expression and clinical significance of P-PDGFR-α in non-small cell lung cancer
ZOU Bin,YANG Yu,LUO Ying-quan.The expression and clinical significance of P-PDGFR-α in non-small cell lung cancer[J].Journal of Difficult and Complicated Cases,2008,7(5):272-276.
Authors:ZOU Bin  YANG Yu  LUO Ying-quan
Institution:( Department of Geriatrics, the Central South University Affiliated Xian.gya Second Hospital, Hunan, Changsha 410011, China)
Abstract:Objective To explore the expression and clinical significance of phospho-platelet derived growth factor receptor-alpha(P-PDGFR-α) in non-small cell lung cancer (NSCLC), and the role of P-PDGFR-α in the progression and metastasis of NSCLC. Methods The expression of P-PDGFR-α in 525 samples of NSCLC was detected using the method of Envision immunohistochemical staining. Results There were 42 samples with the expression of P- PDGFR-α in 525 samples of NSCLC (positive rate 8.0% ).There was rio significant difference between male and female patients in P-PDGFR-α expression( P 〉 0.05). There was no significant difference among different age in P- PDGFR-a expression ( P 〉 0.05) either. There were 21 samples with the expression of P-PDGFR-α in 293 squamous cell carcinoma(SCC) patients( positive rate 7.2% ), 21 samples expression in 222 adenocarcinoma (positive rate 9.5% ), and none sample expression in 11 adenosquamous carcinoma patients. There was no significant difference existed among them in P-PDGFR-α expression( P 〉 0.05);The expression of P-PDGFR-α in high-grade and moderategrade NSCLCs were much lower than that in low-grade NSCLCs ( P 〈 0.05). There.were 266 bronchoscope samples, 26 samples with the expression of P-PDGFR-α in 145 patients who had lymph node metastasis( positive rate 18.0% ), and 8 samples express it in 121 patients who had no metastasis (positive rate 6.7% ), there were significant difference ( P 〈 0.05 ). Conclusion ( 1 ) P-PDGFR-α may be related with the progression and metastasis of NSCLC. ( 2 ) The expression of P-PDGFR-α is irrelevant to gender, age and the pathological types.
Keywords:NSCLC  Phospho-platelet derived growth factor receptor-alpha  Targeted therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号